CS-206 in Patients With Sickle Cell Disease

Clinical trial NCT06565026 · RECRUITING

Trial details

NCT number: NCT06565026
Sponsor: CorrectSequence Therapeutics Co., Ltd
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2024-09-02
Primary completion: 2026-12-31
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.